|
CHMP1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.131600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.554580E-01 |
| Normal-vs-Stage2 |
4.358400E-01 |
| Normal-vs-Stage3 |
5.502200E-01 |
| Normal-vs-Stage4 |
8.727600E-01 |
| Stage1-vs-Stage2 |
7.006000E-01 |
| Stage1-vs-Stage3 |
5.832400E-01 |
| Stage1-vs-Stage4 |
7.899800E-01 |
| Stage2-vs-Stage3 |
9.161400E-01 |
| Stage2-vs-Stage4 |
8.919000E-01 |
| Stage3-vs-Stage4 |
9.246400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.308600E-01 |
| Normal-vs-AfricanAmerican |
3.567200E-01 |
| Normal-vs-Asian |
3.639800E-01 |
| Caucasian-vs-AfricanAmerican |
8.444000E-01 |
| Caucasian-vs-Asian |
5.813000E-01 |
| AfricanAmerican-vs-Asian |
5.289800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.426840E-01 |
| Normal-vs-Female |
5.863600E-01 |
| Male-vs-Female |
2.767800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.851800E-01 |
| Normal-vs-Extreme_Weight |
1.056590E-01 |
| Normal-vs-Obese |
1.737010E-01 |
| Normal-vs-Extreme_Obese |
7.063600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.750000E-01 |
| Normal_Weight-vs-Obese |
5.791200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.134400E-01 |
| Extreme_Weight-vs-Obese |
6.699000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.184400E-01 |
| Obese-vs-Extreme_Obese |
6.221400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.520600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.410400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.617570E-01 |
| Normal-vs-Age(81-100Yrs) |
3.969600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.512200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.164600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.102800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.849400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.035200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.358800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.865200E-01 |
| Normal-VS-Type2 PRCC |
1.882160E-01 |
| Normal-VS-KIRP CIMP |
2.542800E-01 |
| Normal-VS-Unclassified PRCC |
1.378640E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.293400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.435600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.739400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.270790E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.184600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.092650E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.252300E-02 |
| Normal-vs-N1 |
6.215400E-01 |
| Normal-vs-N2 |
7.158400E-01 |
| N0-vs-N1 |
2.140200E-01 |
| N0-vs-N2 |
5.717800E-01 |
| N1-vs-N2 |
6.631800E-01 |
|
|
